{"entity":{"id":"maia-labs","kind":"company","name":"MAIA Labs","aka":["MAIA Labs s.r.o."],"tldr":"MAIA Labs is a Czech company whose software watches the camera feed during a colonoscopy and flags possible polyps, the growths that can turn into bowel cancer. It also writes up the report automatically.","summary":"MAIA Labs s.r.o. is a Brno, Czech Republic, company founded in 2022, according to the company, that develops artificial intelligence for endoscopy. Its ColoMAIA II system plugs into the endoscopy tower to give real-time computer-aided detection (CADe) of polyps with visual and sound alerts, and automates the rest of the procedure record: worklist, recording, withdrawal timing, Boston Bowel Preparation Scale, lesion size estimates, Paris classification suggestions, voice notes and a structured report exported to hospital systems. The company reports CE marking under the EU Medical Device Regulation in 2026, an installation at Mayo Clinic Florida in 2026, and an FDA clearance process under way. Its first registered cancer trial, NCT07563816, a randomised multicentre investigation in Czechia comparing colonoscopy with and without ColoMAIA II assistance in adults aged 40 to 80, with the proportion of patients with at least one adenoma found as the main measure, was posted on ClinicalTrials.gov in May 2026 and is listed as completed.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://maia-labs.com/"},{"label":"About MAIA Labs","url":"https://maia-labs.com/about"},{"label":"ClinicalTrials.gov: randomised trial of ColoMAIA II during colonoscopy (NCT07563816)","url":"https://clinicaltrials.gov/study/NCT07563816"}],"tags":[],"related":[],"cancers":["colorectal"],"sections":["ai-computation","early-detection"],"technologies":["ai-endoscopy-detection"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["The company's headline figure of a 38% increase in adenoma detection rate from its 2025 to 2026 multicentre trial is its own claim; trial results were not found posted on ClinicalTrials.gov and are not recorded here as fact.","The registry contact domain was not given; the company website maia-labs.com was matched by company name and by the ColoMAIA product name.","Financing amounts are not stated on the company website.","Company website read on 29 October 2026."],"hq":"Brno","country":"CZ","companyType":"ai-software","website":"https://maia-labs.com/","founded":2022,"stage":"startup","investors":[],"funding":[]},"route":"/companies/maia-labs/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"ai-endoscopy-detection","kind":"technology","name":"AI polyp detection in colonoscopy","route":"/technologies/ai-endoscopy-detection/"}]}}